cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Kamada Ltd
2 watching
Current Price
$4.76
$0.1
(2.26%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
213.25M
52-Week High
52-Week High
6.18
52-Week Low
52-Week Low
3.721
Average Volume
Average Volume
0.02M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
15.4016
iconMarket Capitalization213.25M
icon52-Week High6.18
icon52-Week Low3.721
iconAverage Volume0.02M
iconDividend Yield--
iconP/E Ratio15.4016
What does the Kamada Ltd do?
Kamada Ltd. develops, produces, and markets plasma-derived protein therapeutics for orphan indications. It operates in two segments, Proprietary Products and Distribution. The company offers Glassia for use in chronic augmentation and maintenance therapy in adults with emphysema due to AATD, KAMRAB/KEDRAB a plasma-derived hyper- immunoglobulin for prophylactic treatment against rabies infection. It also provides KamRho (D) IM to treat prophylaxis of hemolytic disease of newborns; KamRho (D) IV for immune thermobocytopunic purpura; and snake bite antiserum to treat snake bites by the vipera palaestinae and echis coloratus. In addition, the company distributes Bramitob to manage chronic pulmonary infection; FOSTER to treat asthma; PROVOCHOLINE for the diagnosis of bronchial airway hyperactivity; IVIG 5% for the treatment of various immunodeficiency-related conditions; AeroBika, an OPEP device; Varitect, a varicella zoster immunoglobulin; Zutectra and Hepatect CP for the prevention of hepatitis B virus; Megalotect, a CMV immunoglobulin; and RUCONEST for the treatment of acute angioedema attacks in adults with hereditary angioedema. Further, it distributes Heparin sodium injection to treat thrombo-embolic disorders; Albumin and Albumin for maintenance of blood plasma; and coagulation factors comprising Factor VIII and Factor IX, IXIARO vaccine, VIVOTIF for immunization against disease caused by salmonella typhi as well as PROCYSBI, LAMZEDE for metabolic disease, and ELIGARD to treat prostate cancer. It markets its products through strategic partners in the United States, as well as through distributors internationally. Kamada Ltd. has strategic partnerships with Takeda Pharmaceutical Company Limited; PARI GmbH; and Kedrion Biopharma. The company was incorporated in 1990 and is headquartered in Rehovot, Israel.
Read More
News & Events about Kamada Ltd.
Ticker Report
1month ago
Kamada Ltd. (NASDAQ:KMDA Get Rating) saw a large increase in short interest in the month of November. As of November 15th, there was short interest totalling 500,700 shares, an increase of 5.1% from the October 31st total of 476,500 shares. Based on an average daily trading volume, of 33,200...
Globe Newswire
6 months ago
REHOVOT, Israel, July 15, 2022 (GLOBE NEWSWIRE) -- Kamada Ltd. (Nasdaq: KMDA) (KMDA.TA), a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, announced today that the Company, the Employees Union of Kamadas Beit Kama production facility in ...
Ticker Report
9 months ago
StockNews.com assumed coverage on shares of Kamada (NASDAQ:KMDA Get Rating) in a research note released on Monday morning. The firm issued a buy rating on the biotechnology companys stock. Separately, Zacks Investment Research lowered Kamada from a buy rating to a hold rating in a ...
Globe Newswire
10 months ago
New Executives to Strengthen the Companys U.S. Commercial Operations, Focused on Recently Acquired Portfolio of Four FDA-Approved Plasma-Derived Hyperimmune Products, and Planned Opening of New Plasma Collection CentersREHOVOT, Israel, March 14, 2022 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; ...
Ticker Report
1 year ago
Analysts expect Kamada Ltd. (NASDAQ:KMDA) to post $25.20 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have provided estimates for Kamadas earnings. The lowest sales estimate is $24.80 million and the highest is $25.60 million. Kamada posted sales ...
Frequently Asked Questions
Frequently Asked Questions
What is Kamada Ltd share price today?
plus_minus_icon
Can Indians buy Kamada Ltd shares?
plus_minus_icon
How can I buy Kamada Ltd shares from India?
plus_minus_icon
Can Fractional shares of Kamada Ltd be purchased?
plus_minus_icon
What are the documents required to start investing in Kamada Ltd stocks?
plus_minus_icon
What is today’s traded volume of Kamada Ltd?
plus_minus_icon
What is today’s market capitalisation of Kamada Ltd?
plus_minus_icon
What is the 52-Week High and Low Range of Kamada Ltd?
plus_minus_icon
What percentage is Kamada Ltd down from its 52-Week High?
plus_minus_icon
What percentage is Kamada Ltd up from its 52-Week Low?
plus_minus_icon
Current Price
$4.76
$0.1
(2.26%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00